Joseph Cappello's most recent trade in Genelux Corp was a trade of 80,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Sept. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Genelux Corp | Joseph Cappello | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2025 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Genelux Corp | Joseph Cappello | Chief Technical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Sep 2025 | 80,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Genelux Corp | Joseph Cappello | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2025 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Genelux Corp | Joseph Cappello | Chief Technical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Sep 2025 | 65,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Genelux Corp | Joseph Cappello | Chief Technical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Sep 2025 | 16,666 | 0 | - | - | Stock Option (Right to Buy) | |
| Genelux Corp | Joseph Cappello | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2025 | 16,666 | 16,666 | - | - | Stock Option (Right to Buy) | |
| Genelux Corp | Joseph Cappello | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2025 | 13,333 | 13,333 | - | - | Stock Option (Right to Buy) | |
| Genelux Corp | Joseph Cappello | Chief Technical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Sep 2025 | 13,333 | 0 | - | - | Stock Option (Right to Buy) | |
| Genelux Corp | Joseph Cappello | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2025 | 142,500 | 142,500 | - | - | Stock Option (Right to Buy) | |
| Genelux Corp | Joseph Cappello | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2025 | 107,500 | 159,766 | - | 0 | Common Stock | |
| Genelux Corp | Joseph Cappello | VP, Pharmaceutical Development | Sale of securities on an exchange or to another person at price $ 2.92 per share. | 12 May 2025 | 4,737 | 52,266 | - | 2.9 | 13,832 | Common Stock |
| Genelux Corp | Joseph Cappello | VP, Pharmaceutical Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 13,350 | 57,003 | - | 0 | Common Stock | |
| Genelux Corp | Cappello Joseph | VP, Pharmaceutical Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2024 | 39,000 | 39,000 | - | - | Stock Option (right to buy) | |
| Genelux Corp | Joseph Cappello | VP, Pharmaceutical Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2024 | 29,000 | 43,653 | - | 0 | Common Stock | |
| Genelux Corp | Cappello Joseph | VP, Pharmaceutical Development | Sale of securities on an exchange or to another person at price $ 2.34 per share. | 16 Dec 2024 | 6,300 | 14,653 | - | 2.3 | 14,742 | Common Stock |
| Genelux Corp | Joseph Cappello | VP, Pharmaceutical Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2024 | 11,557 | 20,953 | - | 0 | Common Stock | |
| Genelux Corp | Joseph Cappello | VP, Pharmaceutical Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2024 | 3,661 | 9,396 | - | 0 | Common Stock | |
| Genelux Corp | Joseph Cappello | VP, Pharmaceutical Development | Sale of securities on an exchange or to another person at price $ 23.73 per share. | 18 Aug 2023 | 3,265 | 5,735 | - | 23.7 | 77,478 | Common Stock |
| Genelux Corp | Joseph Cappello | VP, Pharmaceutical Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 9,000 | 9,000 | - | 0 | Common Stock |